News & Press: Latest News

MDMA Statement on House Passage of a Full Repeal of the Medical Device Tax

Tuesday, July 24, 2018  
Share |

MDMA Statement on House Passage of a Full Repeal of the Medical Device Tax

Washington, D.C. – Mark Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA), issued the following statement today regarding passage in the House of Representatives of H.R. 184, the “Protect Medical Innovation Act,” which fully repeals the medical device tax:

 “Since MDMA began the fight against the medical device tax in 2009, an overwhelming bipartisan majority has emerged in Congress to put a permanent end to this disastrous policy.  Today’s vote in the House of Representatives is yet another significant step towards achieving this goal.

“The historic tally in support of legislation to fully repeal the medical device tax sends a powerful message that policy makers recognize a suspension of this punitive tax does not allow for the full potential of the innovation ecosystem.

“There continues to be serious challenges facing our nation’s health care delivery system, and medical technology innovators are developing the cures and therapies that will address them.  Fully repealing the medical device tax would allow them to make significant increases to research and development, and to deliver on the promise of better patient care and improved outcomes.

“MDMA urges the Senate to act swiftly to achieve our common goal of putting a permanent end to the medical device tax this year.”